• Successful Eloctaq bid should widen access to the drug in the UK pharmatimes
    June 30, 2020
    The National Health Service (NHS) and Sobi UK have come to an agreement that will give people living with haemophilia A in the UK increased access to Eloctaq (efmoroctocog alfa), by lifting prior volume restrictions for the drug.
PharmaSources Customer Service